ELUVOGUE Trademark

Trademark Overview


On Friday, September 24, 2021, a trademark application was filed for ELUVOGUE with the United States Patent and Trademark Office. The USPTO has given the ELUVOGUE trademark a serial number of 97043169. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, September 2, 2024. This trademark is owned by AbbVie Biotechnology Ltd. The ELUVOGUE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
eluvogue

General Information


Serial Number97043169
Word MarkELUVOGUE
Filing DateFriday, September 24, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbVie Biotechnology Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Party NameAbbVie Biotechnology Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Trademark Events


Event DateEvent Description
Monday, June 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 28, 2021NEW APPLICATION ENTERED
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 27, 2022ASSIGNED TO EXAMINER
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 23, 2023SOU EXTENSION 1 FILED
Thursday, March 23, 2023SOU EXTENSION 1 GRANTED
Saturday, March 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2023SOU EXTENSION 2 FILED
Wednesday, September 13, 2023SOU EXTENSION 2 GRANTED
Friday, March 15, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 15, 2024SOU EXTENSION 3 FILED
Friday, March 15, 2024SOU EXTENSION 3 GRANTED
Monday, September 2, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 2, 2024SOU EXTENSION 4 FILED
Monday, September 2, 2024SOU EXTENSION 4 GRANTED
Saturday, March 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED